HEMATOLOGIC CANCER
Clinical trials for HEMATOLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC CANCER trials appear
Sign up with your email to follow new studies for HEMATOLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New model aims to help cancer patients manage multiple health issues
Disease control Recruiting nowThis study tests a new way to care for cancer patients who also have other chronic conditions like diabetes or high blood pressure. It brings together cancer doctors and primary care providers to improve communication and support. The goal is to help patients better manage their …
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Exercise and diet may tame brain fog from cancer therapy
Symptom relief Recruiting nowThis study tests whether exercise and nutrition can lower the risk or severity of brain-related side effects (neurotoxicity) caused by CAR-T cell therapy in adults with blood cancers. One hundred participants will be randomly assigned to a structured exercise program, exercise pl…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: Instituto de Investigacion Sanitaria INCLIVA • Aim: Symptom relief
Last updated May 26, 2026 03:19 UTC
-
Hypnosis offers new hope for blood cancer anxiety
Symptom relief Recruiting nowThis study looks at whether hypnosis can help reduce anxiety in adults recently diagnosed with certain blood cancers (like lymphoma). Fifty participants will receive hypnosis sessions, and researchers will measure their anxiety levels before and after treatment. The goal is to se…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC
-
New study tackles food insecurity in cancer patients
Knowledge-focused Recruiting nowThis study is testing a program called MyCarePulse and ASCENT to help cancer patients overcome food-related challenges. About 100 adults recently diagnosed with certain cancers will either receive the program or standard care. Researchers will measure changes in food security, di…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated May 26, 2026 03:19 UTC
-
Myeloma breakthrough? study tests if patients can ditch lifelong drugs
Knowledge-focused Recruiting nowThis study looks at whether people with multiple myeloma who have achieved a very deep remission (called MRD-negative) and have been on maintenance therapy for at least two years can stop that therapy without their cancer coming back. Researchers will follow 70 participants for u…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: University College Cork • Aim: Knowledge-focused
Last updated May 26, 2026 03:07 UTC
-
New study aims to make cancer trials more fair for minorities and older adults
Knowledge-focused Recruiting nowThis study tests whether extra support—like a patient navigator, text message check-ins, and an educational video—can help Black, Latinx, and older adults (70+) with advanced cancer get the genomic testing needed to join precision cancer trials. About 210 participants with gastro…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: Nadine McCleary, MD, MPH • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC
-
Massive cancer gene study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study will collect genetic information and health records from 25,000 people who have cancer or are at risk for it. The goal is to learn more about what drives cancer and how to better tailor treatments. Participants will not receive a new therapy, but their data may help fu…
Matched conditions: HEMATOLOGIC CANCER
Sponsor: Avera McKennan Hospital & University Health Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC
-
New study aims to predict dangerous immune reactions in blood cancer patients
Knowledge-focused Recruiting nowThis study watches 100 adults with blood cancers like lymphoma who are getting CAR T-cell or bispecific antibody therapy. Researchers track vital signs and immune markers to find early clues that a serious complication called cytokine release syndrome (CRS) may be developing. The…
Matched conditions: HEMATOLOGIC CANCER
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC